Sagebrush Health Services has filed a lawsuit against Amgen, alleging unlawful termination of discounted drug sales under the ...
The American Hospital Association is once again raising concerns about how a major drugmaker handles the government’s 340B ...
Health Affairs' Rob Lott interviews Sayeh Nikpay of the University of Minnesota about her recent paper exploring how The Medicaid Drug Rebate Program and the 340B Program interact in ways that can ...
The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...
The cost of prescription drugs is certain to be a hot-button issue in the coming Illinois legislative session with two separate measures making for curious bedfellows in Springfield.
On January 15, 2026, President Trump released a one-page health policy framework. Among other things, the document includes calls for ...
The American Hospital Association is asking the Trump administration to stop Eli Lilly from enacting a new policy as part of ...
The 340B drug pricing plan is meant to help low-income patients. It needs better oversight in this state.
The view inside a CVS pharmacy. (Photo by Lynne Terry/Oregon Capital Chronicle) In May 2025, Gov. Jared Polis signed Senate Bill 71 into law, dramatically expanding Colorado’s participation in the ...
Pharmaceutical companies have raised prices on hundreds of drugs so far this month despite federal efforts to rein in drug ...
9d
Amgen (AMGN) Faces 340B Lawsuit: What Does Sagebrush Dispute Reveal About Its Stakeholder Strategy?
Sagebrush Health Services has filed a lawsuit in California state court accusing Amgen of unlawfully cutting off 340B discounted drug sales to its Nevada clinics and reclaiming at least US$7,000,000 ...
Continued support of 340B is vital for diverse communities and small business owners in the state.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results